FDA expands meningitis vaccine approval

October 22, 2007

The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.

Menactra was first approved by the FDA in January 2005 for people ages 11 to 55. The vaccine Menomune was previously the only meningococcal vaccine available in the United States for use in children ages 2 and older, the FDA said Thursday in a release.

Both products are manufactured by Sanofi Pasteur Inc. of Swiftwater, Pa.

Meningitis, a serious inflammation of the lining that surrounds the spinal cord and brain, can cause death or permanent brain injury.

Copyright 2007 by United Press International

Explore further: FDA approves Merck's Zinplava to reduce recurrence of Clostridium difficile infection

Related Stories

Researchers develop new candidate vaccines against the plague

October 13, 2016

Researchers from The University of Texas Medical Branch at Galveston have developed new potential vaccines that protect animals against the bacteria that causes the deadly plague. These findings are detailed in NPJ Vaccines.

FDA approves vaccine for cholera

June 11, 2016

In a milestone years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine's Center for Vaccine Development, was approved today by the U.S. Food ...

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.